Found: 20
Select item for more details and to access through your institution.
Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease.
- Published in:
- Nature Communications, 2023, v. 14, p. 1, doi. 10.1038/s41467-023-37209-1
- By:
- Publication type:
- Article
Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2).
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 7, p. 1745, doi. 10.1210/clinem/dgae038
- By:
- Publication type:
- Article
Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2021, v. 106, n. 2, p. 388, doi. 10.1210/clinem/dgaa863
- By:
- Publication type:
- Article
Circulating FGF21 proteolytic processing mediated by fibroblast activation protein.
- Published in:
- Biochemical Journal, 2016, v. 473, n. 5, p. 605, doi. 10.1042/BJ20151085
- By:
- Publication type:
- Article
Developmental Aspects of the Endocrine Pancreas.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2003, v. 4, n. 1, p. 5
- By:
- Publication type:
- Article
Reflecting on the Importance of Webinars in Cancer Education.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Improvements in post‐challenge lipid response following tirzepatide treatment in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 785, doi. 10.1111/dom.15365
- By:
- Publication type:
- Article
Virtual Reality in Cancer Care: Enhancing Knowledge and Reducing Anxiety about Chemotherapy among Patients and Caregivers.
- Published in:
- International Journal of Environmental Research & Public Health, 2024, v. 21, n. 9, p. 1163, doi. 10.3390/ijerph21091163
- By:
- Publication type:
- Article
Stromal cell derived factor-1 (SDF-1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Stromal Cell-Derived Factor-1 (SDF-1)/CXCL12 Attenuates Diabetes in Mice and Promotes Pancreatic β-Cell Survival by Activation of the Prosurvival Kinase Akt.
- Published in:
- Diabetes, 2007, v. 56, n. 12, p. 2946, doi. 10.2337/db07-0291
- By:
- Publication type:
- Article
Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Hedgehog signaling regulation of insulin production by pancreatic beta-cells.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2023, v. 46, n. 5, p. 998, doi. 10.2337/dc22-1710
- By:
- Publication type:
- Article
Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH).
- Published in:
- 2018
- By:
- Publication type:
- journal article
1216-P: Plasma Amino Acid Profile as a Predictive Biomarker for Visceral Adiposity in Japanese Americans.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1216-P
- By:
- Publication type:
- Article
682-P: Novel Dual Glucagon and Glucagon-Like Peptide-1 Receptor Agonist LY3305677 Improves Glucose Control, Reduces Body Weight, and Increases Energy Expenditure in Mice.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-682-P
- By:
- Publication type:
- Article
106-OR: A First-in-Human Single Ascending Dose Study of Oxyntomodulin Analog LY3305677 in Healthy Subjects.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-106-OR
- By:
- Publication type:
- Article
104-OR: Novel GIP/GLP-1/Glucagon Receptor Agonist LY3437943: A First-in-Human Dose Study in Healthy Subjects.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-104-OR
- By:
- Publication type:
- Article
980-P: Tirzepatide, a Dual GIP and GLP-1 Receptor Agonist, Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes Patients.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-980-P
- By:
- Publication type:
- Article
20-OR: GPR142 Agonists Increase Glucose-Dependent Insulin Secretion and Differentially Regulate Hormone Secretion in Preclinical and Phase 1 Studies.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-20-OR
- By:
- Publication type:
- Article